✦ LIBER ✦

Novel vascular targeting/disrupting agents: Combretastatin A4 phosphate and related compounds

✍ Scribed by Matthew M. Cooney; Jose Ortiz; Ronald M. Bukowski; Scot C. Remick

Book ID: 107546371
Publisher: Current Science Inc.
Year: 2005
Tongue: English
Weight: 268 KB
Volume: 7
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-005-0033-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p38 MAPK, but not ERK1/2, is critically

p38 MAPK, but not ERK1/2, is critically involved in the cytotoxicity of the novel vascular disrupting agent combretastatin A4

✍ Haitian Quan; Yongping Xu; Liguang Lou 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 739 KB

## Abstract Combretastatin A4 (CA4) is a novel vascular disrupting agent that has promising clinical efficacy because of its ability to inhibit microtubule assembly and subsequently disrupt tumor blood flow. In this study, we demonstrate that mitogen‐activated protein kinases (MAPKs) are critically

ChemInform Abstract: 4-(β-Arylvinyl)-3-(

ChemInform Abstract: 4-(β-Arylvinyl)-3-(β-arylvinylketo)-1-ethyl-4-piperidinols and Related Compounds: A Novel Class of Cytotoxic and Anticancer Agents.

✍ J. R. DIMMOCK; S. C. VASHISHTHA; J. W. QUAIL; U. PUGAZHENTHI; Z. ZIMPEL; A. M. S 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB 👁 1 views